Characteristics and outcomes among patients with community-acquired respiratory virus infections during the first year after lung transplantation.
Luke D MahanRohan KanadeManish R MohankaSrinivas BollineniJohn JoernsVaidehi KazaFernando TorresRicardo M La HozAmit BangaPublished in: Clinical transplantation (2020)
There is a significant burden of CARV infections during the first year after LT. The use of nasal corticosteroids may increase the risk of CARV infection. CARV infections did not impact outcomes.